These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1557484)

  • 41. Chronic obstructive pulmonary disease and depression: analysis of depressive symptoms.
    Thornton A; Yohannes AM; Baldwin RC; Connolly MJ
    Age Ageing; 2000 May; 29(3):286-7. PubMed ID: 10855916
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychological aspects of chronic obstructive pulmonary disease.
    Agle DP; Baum GL
    Med Clin North Am; 1977 Jul; 61(4):749-58. PubMed ID: 559893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotics or placebo for chronic obstructive pulmonary disease.
    Dudek JJ; Heaney RM
    Ann Intern Med; 1987 Jul; 107(1):117-8. PubMed ID: 3592433
    [No Abstract]   [Full Text] [Related]  

  • 44. Sertraline effects on dyspnea in patients with obstructive airways disease.
    Smoller JW; Pollack MH; Systrom D; Kradin RL
    Psychosomatics; 1998; 39(1):24-9. PubMed ID: 9538672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.
    Papp LA; Weiss JR; Greenberg HE; Rifkin A; Scharf SM; Gorman JM; Klein DF
    Am J Psychiatry; 1995 Oct; 152(10):1531. PubMed ID: 7573598
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD.
    Eiser N; Harte R; Spiros K; Phillips C; Isaac MT
    COPD; 2005 Jun; 2(2):233-41. PubMed ID: 17136950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial.
    He Y; Zheng Y; Xu C; Yang H; Wang Z; Zhou L; Wan Y; Zheng D; Zhu J
    Clin Respir J; 2016 May; 10(3):318-25. PubMed ID: 25308771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between depression and anxiety index and frequency of acute exacerbation in chronic obstructive pulmonary disease.
    Hong YJ; Kim Y; Moon JY; Park S; Lee JK; Jung KS; Yoo KH; Kim YI; Choi JY
    Ther Adv Respir Dis; 2023; 17():17534666231216591. PubMed ID: 38108295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.
    Recio Iglesias J; Díez-Manglano J; López García F; Díaz Peromingo JA; Almagro P; Varela Aguilar JM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1015-1037. PubMed ID: 32440113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression.
    Bessette KL; Karstens AJ; Crane NA; Peters AT; Stange JP; Elverman KH; Morimoto SS; Weisenbach SL; Langenecker SA
    Neuropsychol Rev; 2020 Dec; 30(4):477-498. PubMed ID: 31942706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanism of noradrenaline during the stress-induced major depressive disorder.
    Seki K; Yoshida S; Jaiswal MK
    Neural Regen Res; 2018 Jul; 13(7):1159-1169. PubMed ID: 30028316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
    Simon ST; Higginson IJ; Booth S; Harding R; Weingärtner V; Bausewein C
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007354. PubMed ID: 27764523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors Associated with Depression in COPD: A Multicenter Study.
    Martinez Rivera C; Costan Galicia J; Alcázar Navarrete B; Garcia-Polo C; Ruiz Iturriaga LA; Herrejón A; Ros Lucas JA; García-Sidro P; Tirado-Conde G; López-Campos JL; Mayoralas Alises S; de Miguel-Díez J; Esquinas C; Miravitlles M
    Lung; 2016 Jun; 194(3):335-43. PubMed ID: 26932809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.
    Tselebis A; Pachi A; Ilias I; Kosmas E; Bratis D; Moussas G; Tzanakis N
    Neuropsychiatr Dis Treat; 2016; 12():297-328. PubMed ID: 26929625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.
    Singh G; Zhang W; Kuo YF; Sharma G
    Chest; 2016 Apr; 149(4):905-15. PubMed ID: 26204260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can early introduction of specialized palliative care limit intensive care, emergency and hospital admissions in patients with severe and very severe COPD? a randomized study.
    Weber C; Stirnemann J; Herrmann FR; Pautex S; Janssens JP
    BMC Palliat Care; 2014 Oct; 13():47. PubMed ID: 25927907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anxiety and depression-Important psychological comorbidities of COPD.
    Pumar MI; Gray CR; Walsh JR; Yang IA; Rolls TA; Ward DL
    J Thorac Dis; 2014 Nov; 6(11):1615-31. PubMed ID: 25478202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.
    Avari JN; Alexopoulos GS
    Am J Geriatr Psychiatry; 2015 May; 23(5):477-87. PubMed ID: 25028344
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.